Show simple item record

dc.contributor.authorBusch, Kia
dc.contributor.authorAndersen, Andreas G.
dc.contributor.authorPetersen, Jørgen B.B.
dc.contributor.authorPetersen, Stine E.
dc.contributor.authorRønde, Heidi S.
dc.contributor.authorBentzen, Line
dc.contributor.authorPilskog, Sara Margareta Cecilia
dc.contributor.authorSkyt, Peter
dc.contributor.authorNørrevang, Ole
dc.contributor.authorMuren, Ludvig Paul
dc.date.accessioned2023-01-06T15:08:39Z
dc.date.available2023-01-06T15:08:39Z
dc.date.created2022-05-23T13:25:42Z
dc.date.issued2022
dc.identifier.issn2057-1976
dc.identifier.urihttps://hdl.handle.net/11250/3041663
dc.description.abstractIntroduction: Internal organ motion and deformations may cause dose degradations in proton therapy (PT) that are challenging to resolve using conventional image-guidance strategies. This study aimed to investigate the potential of range guidance using water-equivalent path length (WEPL) calculations to detect dose degradations occurring in PT. Materials and methods: Proton ranges were estimated using WEPL calculations. Field-specific isodose surfaces in the planning CT (pCT), from robustly optimised five-field proton plans (opposing lateral and three posterior/posterior oblique beams) for locally advanced prostate cancer patients, were used as starting points. WEPLs to each point on the field-specific isodoses in the pCT were calculated. The corresponding range for each point was found in the repeat CTs (rCTs). The spatial agreement between the resulting surfaces in the rCTs (hereafter referred to as iso-WEPLs) and the isodoses re-calculated in rCTs was evaluated for different dose levels and Hausdorff thresholds (2–5 mm). Finally, the sensitivity and specificity of detecting target dose degradation (V95% < 95%) using spatial agreement measures between the iso-WEPLs and isodoses in the pCT was evaluated. Results: The spatial agreement between the iso-WEPLs and isodoses in the rCTs depended on the Hausdorff threshold. The agreement was 65%–88% for a 2 mm threshold, 83%–96% for 3 mm, 90%–99% for 4 mm, and 94%–99% for 5 mm, across all fields and isodose levels. Minor differences were observed between the different isodose levels investigated. Target dose degradations were detected with 82%–100% sensitivity and 75%–80% specificity using a 2 mm Hausdorff threshold for the lateral fields. Conclusion: Iso-WEPLs were comparable to isodoses re-calculated in the rCTs. The proposed strategy could detect target dose degradations occurring in the rCTs and could be an alternative to a fully-fledged dose re-calculation to detect anatomical variations severely influencing the proton range.en_US
dc.language.isoengen_US
dc.publisherIOP Publishingen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleTowards range-guidance in proton therapy to detect organ motion-induced dose degradationsen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 the authorsen_US
dc.source.articlenumber025018en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1088/2057-1976/ac5151
dc.identifier.cristin2026541
dc.source.journalBiomedical Engineering & Physics Expressen_US
dc.identifier.citationBiomedical Engineering & Physics Express. 2022, 8 (2), 025018.en_US
dc.source.volume8en_US
dc.source.issue2en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal